0000000000880540

AUTHOR

Renato Reyes

showing 1 related works from this author

LEOPARD-II: A randomized phase II study of radiochemotherapy (RCT) with 5FU and cisplatin plus/minus cetuximab (Cet) in unresectable locally advanced…

2014

4081 Background: Patients (pts) with LAEC have a poor prognosis; new therapies are required. A study showed the addition of Cet to RCT to be safe and effective for resectable EC [Ruhstaller et al, ...

CisplatinOncologyCancer ResearchPoor prognosismedicine.medical_specialtyCetuximabbusiness.industryLocally advancedPhases of clinical researchEsophageal cancermedicine.diseaselaw.inventionOncologyRandomized controlled triallawInternal medicinemedicinebusinessmedicine.drugJournal of Clinical Oncology
researchProduct